SU1499236A1 - Method of treatment of atherosclerotic ischemia of the lower limbs - Google Patents

Abstract

The invention relates to the field of medicine, namely physiotherapy, and can be used to treat atherosclerotic ischemia of the lower extremities. The aim of the invention is to reduce the duration of treatment. For this, the level of catalase activity is determined in the patient's blood during treatment. Treatment by exposure to laser radiation with a wavelength of 632.8 nm with an intensity of 1-30 mW on the projection region of the lumbar sympathetic ganglia and on the projection of the vascular primary bundles of the legs and feet is carried out until the level of catalase activity reaches normal values. The method is not complicated, it allows, in comparison with the known methods of physiotherapeutic treatment of atherosclerotic ischemia of the lower extremities, to shorten the treatment time by 7-10 days in 80% of patients, which reduces the costs of hospitalization and treatment.

Description

The invention relates to medicine, namely physiotherapy, and can be used to treat atherosclerotic ischemia of the lower extremities.

The aim of the invention is to reduce the duration of treatment.

The method is carried out as follows.

Before the beginning of treatment on an empty stomach, a patient with atherosclerosis of the vessels of the lower extremities is sampled from an elbow vein in an amount of 3–5%, from which blood serum is obtained by a conventional method. Then, about 15 MP of serum is placed in a commonly used for polarographic research cell with a Clark electrode connected to a serial production floor (for example, Lp-7, Czechoslovakia), and at a potential of 0.6 V, the rate of oxygen evolution during decomposition is recorded Oh, i ml of 10 millimolar hydrogen peroxide. The value of this rate obtained in this way reflects the activity of the catalase enzyme contained in this serum (this activity is expressed in international units ME). Then, the initial level of catalase activity of the patient with atherosclerosis of the lower extremities vessels is compared with the activity value of this enzyme, determined by the preliminary

CD QD BE

oo Ci

for healthy individuals (dopor). After that, the patient is cozied on a couch, on the stomach, and acted upon by a continuous monochromatic laser radiation with a wavelength of 0.6328 µm at an intensity of 1–30 mW on the projection region of the match sympathetic ganglia (median lipid at the z-z level). and on the nrock vascular of the hundred-nerve bundles of the legs (right and left knees) and stop (right and left inner ankles). The duration of irradiation in each procedure is established taking into account the individual response of the patient. After the time the procedure is considered complete. Subsequently, during the course of treatment (before the next procedure), repeated measurements of the level of catalase activity in the blood are carried out in the indicated manner. The course dose of exposure to continuous monochromatic radiation with a wavelength of 0, 6328 mkm is considered sufficient and treatment ends when the level of catalase activity in the blood ceases to increase as well as when this activity reaches the level of healthy individuals (5913.6x).

Example 1. Patient A, Diagnosis: atherosclerosis of the vessels of the lower extremities. Occlusion of the femoral arteries. Disease duration is 10 years. Previous treatment is outpatient, medical. Complaints of pain in the calf muscles at one walk, with a moan. Examination: pulse is not detected palpably on both anterior and posterior tibial arteries and on both femoral arteries. The reovasographic study: B1 is an intravenous decrease in blood filling in the lower legs and feet. The initial level of blood catalase activity is 44 (catalase activity in healthy individuals is 59 ± 3.6 -10-ME).

Treatment: the effect of continuous monochromatic laser radiation with a wavelength of 0.6328 microns on the projection of the lumbar sympathetic ganglia, neurovascular, leg bundles and moans at an intensity of 1 mW / cm, for a duration of 5 min, daily. The level of catalase activity in the blood after 10 procedures was 55 th ME and its further increase during subsequent irradiation did not occur.

Q 5 0 5 0

Q

five

0

lo The course of treatment has been completed. Geographical study: Compared with RVG, blood flow in the area of both legs and feet will significantly increase. The follow-up period: 11 months. According to rheovasography, signs of an increase in chronic arterial insufficiency caused by atherosclerotic vascular lesions were not observed.

Example 2. Patient C-V.L. Diagnosis: atherosclerosis of the lower extremities. Occlusion of the right ileal artery .and left femoral. Disease duration is 8 months. Previous treatment is inpatient, medical. Complaints of pain in the calf-muscle while walking. Examination: pulse is not palpable on both anterior, posterior tibial arteries and right femoral artery. On the left femoral artery, pulse palpation weakened. Reovasographic study: pronounced decrease in blood filling in the region of both legs and feet. The initial level of catalase activity of blood ZZ-Yu (catalase activity in healthy individuals is 5913.6).

Treatment: exposure to continuous monochromatic laser radiation with a wavelength of 0.6328 μm on projected lumbar sympathetic ganglia, neurovascular bundles of the legs and feet at an intensity of 30 mW / cm, for a duration of 2 minutes, daily. The level of catalase activity in the blood after 7 procedures was 60 U - MB,. those. reached the norm. The course of treatment has been completed. Eographical study: Compared with RVG, the outcome significantly increased blood filling in the region of both legs and feet.

The follow-up period: 14 months. According to rheovasography, signs of an increase in chronic arterial insufficiency caused by atherosclerotic lesions of the leg vessels were not observed.

The treatment of the proposed method was subjected to 55 people. A positive effect when using the proposed method in comparison with the known method is to shorten the treatment time by 7-10 days in 80%

514992366

patients, which reduces the cost of state intensity from 1 to 30 mW / cm, about the tpitalization and treatment.

shorten the treatment time

Claims (1)

Claims. carried out under the control of the measurement of k-a method for treating atherosclerotic catalase in serum, lower limb ischemia by and procedures are carried out before conducting a course of radiation effects to achieve a normal activity level of a laser with a dpine wavelength of 632.8 nm and minimum values .